2.1 Dosage for Postherpetic Neuralgia - In adults with postherpetic neuralgia, gabapentin capsules may be initiated on Day 1 as a single 300 mg dose, on Day 2 as 600 mg/day (300 mg two times a Gabapentin is commonly used off-label in the treatment of psychiatric disorders with success, failure, and controversy. A systematic review of the literature was performed to elucidate the evidence for clinical benefit of gabapentin in psychiatric disorders. We conducted a systematic review and meta-analysis of the evidence for three of their common psychiatric uses: bipolar disorder, anxiety, and insomnia. Gabapentin is a nerve pain medication and anticonvulsant that has proven to be effective for people who have hard-to-treat depression or other mood disorders. Today, gabapentin is frequently prescribed off-label for various mental health conditions, joining the ranks of other mood-stabilizing medications like lamotrigine, which has shown promise in treating bipolar disorder and depression. The gabapentinoids, gabapentin, and pregabalin, target the α2δ subunits of voltage-gated calcium channels. Initially licensed for pain and seizures, they have become widely prescribed drugs. Many of these uses are off-label for psychiatric Objective: Gabapentin is widely prescribed off label in medical practice, including psychiatry. The U.S. Food and Drug Administration (FDA) warned of risks associated with gabapentin combined with central nervous system depressant (CNS-D) drugs, which are commonly prescribed in psychiatric treatment. This study examined off-label outpatient gabapentin use for psychiatric indications and Objective: Gabapentin is widely prescribed off label in medical practice, including psychiatry. The U.S. Food and Drug Administration (FDA) warned of risks associated with gabapentin combined with central nervous system de-pressant (CNS-D) drugs, which are commonly prescribed in psychiatric treatment. This study examined off-label outpatient gabapentin use for psychiatric indications and By blocking dopamine receptors, antipsychotics can help to reduce hallucinations, delusions, and disorganized thinking. While gabapentin is not approved to treat psychiatric conditions, it may sometimes be used off-label in combination with other medications to help manage certain symptoms. Gabapentin: long-term anti-anxiety and hypnotic effects in psychiatric patients with comorbid anxiety-related disorders [letter] Can J Psychiatry. 1998;43:305. [PubMed] [Google Scholar] Identify the appropriate indications for gabapentin therapy, including neuropathic pain, partial onset seizures, restless legs syndrome, and other relevant neurological and psychiatric conditions. Sources GoodRx Health | Gabapentin for Anxiety: Dosing, Side Effects, and More IUPHAR/BPS Guide to Pharmacology |Gabapentin Innovations in Clinical Neuroscience | Psychiatric Uses of Gabapentin StatPearls | Propranolol Mental Health America | What is GABA? The Journal of Clinical Psychiatry | The Role of GABA in Anxiety Disorders Objective: This article reviews evidence-based psychiatric uses of gabapentin, along with associated risks. Method of Research: An extensive literature review was conducted, primarily of articles searchable in PubMed, relating to psychiatric uses, safety, and adverse effects of gabapentin. Results: Evidence supports gabapentin as a treatment for alcohol withdrawal and alcohol use disorder While gabapentin is frequently used in practice for a wide array of psychiatric diagnoses, its use is evidence-based for only a few indications. Multiple RCTs have shown gabapentin to be ineffective for bipolar disorder. Additional systematic reviews, meta-analyses, or other primary literature Evidence from the literature of known off-label indications is generally lacking, based on modest to no effect on relevant clinical outcomes, with the exception of RLS (Table 2). Berlin et al 21 recently conducted a systematic review on gabapentin across several psychiatric disorders. For depression, use mainly comprised Outpatient prescription of gabapentin for FDA-approved indications (i.e., partial-onset seizures and postherpetic neuralgia) was less than 1%, and depression and anxiety disorders were the most frequent psychiatric diagnoses among off-label users. Gabapentin is commonly used off-label in the treatment of psychiatric disorders with success, failure, and controversy. A systematic review of the literature was performed to elucidate the evidence for clinical benefit of gabapentin in psychiatric disorders. While gabapentin is frequently used in practice for a wide array of psychiatric diagnoses, its use is evidence-based for only a few indications. Multiple RCTs have shown gabapentin to be ineffective for bipolar disorder. FROM THE EDITOR To keep up-to-date with the voluminous psychiatric literature, I scan many psychiatric and neuroscience publications in search of articles that pull me in for a deeper look. Recently, I skimmed the titles of a weekly email newsletter I receive and was immediately drawn to the first article: “Before You Prescribe Gabapentin, Consider These Risks.” 1 The first sentence of the In this nationally representative sample, <1% of outpatient gabapentin use was for approved indications. High concomitant use of CNS-D drugs and off-label gabapentin for psychiatric diagnoses underlines the need for improved communication about safety.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |